Skip to main content

Table 1 Correlation between GOLT1B expression and clinicopathological features in CRC patients

From: Vesicle transporter GOLT1B mediates the cell membrane localization of DVL2 and PD-L2 and promotes colorectal cancer metastasis

Variables Low GOLT1B (n = 72) High GOLT1B (n = 152) P value
Gender    1.0000
 Male 41 (56.9%) 87 (57.2%)  
 Female 31 (43.1%) 65 (42.8%)  
Median age    0.0099**
 < 67 years 45 (62.5%) 66 (42.4%)  
 ≥ 67 years 27 (37.5%) 86 (56.6%)  
pT stage    0.6430
 T1 4 (5.6%) 13 (8.5%)  
 T2 19 (26.4%) 31 (20.4%)  
 T3 41 (56.9%) 91 (59.9%)  
 T4 8 (11.1%) 17 (11.2%)  
pN stage     < 0.0002***
 N0 63 (87.5%) 98 (64.5%)  
 N1 7 (9.7%) 44 (28.9%)  
 N2 2 (2.8%) 10 (6.6%)  
pM stage    0.0005***
 M0 71 (98.6%) 127 (83.6%)  
 M1 1 (1.4%) 25 (16.4%)  
Histological grade    0.3711
 G1 3 (4.2%) 8 (5.3%)  
 G2 40 (55.6%) 93 (61.2%)  
 G3 29 (40.2%) 51 (33.5%)  
  1. All data are shown as numbers and percentages. Low GOLT1B is defined as IHC score < 5 and High GOLT1B is defined as IHC score ≥ 5. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001